CHICAGO -- Intravenous doses of a synthetic component of "good" cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation's No. 1 ...
CHICAGO -- Intravenous doses of a synthetic component of "good" cholesterol reduced artery disease in just six weeks in a small study with startlingly big implications for treating the nation's No. 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback